Literature DB >> 718555

A survey of antibody to Aino virus in cattle and other species in Australia.

D H Cybinski, T D St George.   

Abstract

A serological survey of healthy cattle in Australia showed that antibodies to Aino virus were present in serums from cattle in northern Australia and down the east coast as far as central New South Wales in 1975, 1976 and 1977, but occurred with a lower frequency than antibodies to Akabane virus. In contrast to the findings with Akabane virus, no neutralising antibodies to Aino virus were detected in serums from camels, dogs or horses. Antibodies to both viruses were detected in buffaloes and sheep, but not in humans or any of the Australian indigenous species so far tested. All positive serums originated from within the known range of Culicoides brevitarsis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718555     DOI: 10.1111/j.1751-0813.1978.tb02504.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  4 in total

1.  Presence of antibodies to Schmallenberg virus in a dog in Sweden.

Authors:  Jonas Johansson Wensman; Gunilla Blomqvist; Maj Hjort; Bodil Ström Holst
Journal:  J Clin Microbiol       Date:  2013-06-05       Impact factor: 5.948

2.  Teratogenicity of Australian Simbu serogroup and some other Bunyaviridae viruses: the embryonated chicken egg as a model.

Authors:  D A McPhee; I M Parsonson; A J Della-Porta; R G Jarrett
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

3.  Detection of serum neutralizing antibodies to Simbu sero-group viruses in cattle in Tanzania.

Authors:  Coletha Mathew; S Klevar; A R W Elbers; W H M van der Poel; P D Kirkland; J Godfroid; R H Mdegela; G Mwamengele; M Stokstad
Journal:  BMC Vet Res       Date:  2015-08-15       Impact factor: 2.741

Review 4.  Virus-induced congenital malformations in cattle.

Authors:  Jørgen S Agerholm; Marion Hewicker-Trautwein; Klaas Peperkamp; Peter A Windsor
Journal:  Acta Vet Scand       Date:  2015-09-24       Impact factor: 1.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.